Our Services
Medical Information
Helpful Resources
Published on: 4/29/2026
Melasma often persists due to factors like UV and visible light exposure, hormonal influences, genetic predisposition and skin barrier inflammation. PRP may support collagen remodeling and reduce inflammation as an adjunct to topical or device-based therapies but is not a standalone cure for pigmentation.
See below for more details on optimizing sun protection, topical therapies, peels, lasers and medical next steps to achieve sustained improvement.
Melasma is a common pigment disorder characterized by brown or gray-brown patches, most often on the cheeks, forehead and upper lip. While it isn't dangerous, it can be stubborn. Understanding why melasma persists—and exploring options like PRP for melasma—can help you set realistic expectations and choose the best next steps.
Melasma is more than "just" discoloration. Multiple factors can keep it from fading:
Ultraviolet (UV) and Visible Light Exposure
Hormonal Influences
Genetic Predisposition
Skin Barrier and Inflammation
Treatment Gaps and Relapses
Platelet-rich plasma (PRP) therapy has gained popularity for skin rejuvenation. Interest in "PRP for melasma" has grown—but how well does it work?
| Pros | Cons |
|---|---|
| Uses patient's own blood—low allergy risk | Costly, often not covered by insurance |
| May improve skin texture and glow | Multiple sessions needed |
| Minimal downtime compared to lasers | Variable effectiveness for melasma pigment |
| Can be combined with other treatments | Risk of bruising, infection, or discomfort |
A multi‐modality, long‐term approach often yields the best results:
Melasma is chronic, but professional care can accelerate improvement and reduce relapses. Consider these steps:
If you're experiencing any unusual skin symptoms or want to better understand what might be causing your pigmentation concerns before your appointment, try Ubie's free Medically approved LLM Symptom Checker Chat Bot to get personalized insights and help identify potential underlying conditions.
If you notice any severe reactions (extreme redness, swelling, blistering) or have concerns that something more serious is going on, speak to a doctor right away. Always consult a qualified healthcare professional before starting or changing treatments, especially anything involving prescription medications or medical devices.
(References)
* Passi, S., & Bhardwaj, M. (2021). The role of inflammation and vascularity in the pathogenesis and treatment of melasma. *Journal of Cosmetic Dermatology*, *20*(4), 1146-1153. PMID: 33795325
* El-Moftya, M. S., Abdelwahed, S. R., & Mosaad, M. N. (2022). Platelet-rich plasma for the treatment of melasma: A systematic review and meta-analysis. *Journal of Cosmetic Dermatology*, *21*(2), 498-510. PMID: 35023903
* El-Hawary, M. S., Youssef, S. A., & Abdelhady, S. M. (2022). Efficacy of intradermal injection of platelet-rich plasma and tranexamic acid in combination with fractional CO2 laser for refractory melasma: a split-face study. *Journal of Cosmetic Dermatology*, *21*(6), 2541-2549. PMID: 35552392
* Saravanan, P., Pandhi, D., & Kaur, T. (2022). Management of refractory melasma: An algorithmic approach. *Indian Dermatology Online Journal*, *13*(1), 1-13. PMID: 35032543
* Sofen, B., & Chang, P. C. (2021). Melasma: A comprehensive review of established and emerging treatments. *Dermatology and Therapy*, *11*(4), 1195-1212. PMID: 34267420
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.